Interventional Cardiology Devices Market By Product Type Balloons, Percutaneous Transluminal Coronary, Angioplasty Guide Wires, Stents, Catheters, Inferior Vena Cava Filters, Intravascular Ultrasound Systems, Left Atrial Appendage Devices and Others), By Disease Type, By End User and Region Forecast 2019-2030

Interventional Cardiology Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons, Percutaneous Transluminal Coronary, Angioplasty (PTCA) Guide Wires, Stents, Catheters, Inferior Vena Cava (IVC) Filters, Intravascular Ultrasound Systems, Left Atrial Appendage (LAA) Devices and Others), By Disease Type (Congestive Heart Disease, Percutaneous Valve Replacement, Percutaneous Valve Repair, Coronary Thrombectomy, Others), By End User (Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centres) and Region Forecast 2019-2030

Interventional cardiology devices market size was valued at US$ 14.9 billion in 2023 and is projected to reach a value of US$ 24.6 billion by 2030, at a CAGR of 8.9 from 2024-2030. Interventional cardiology deals with the treatment of various heart diseases by using intravascular catheter-based techniques. Interventional cardiology devices are commonly used in the treatment of coronary artery disease, conventional artery disease, and aneurysm. In this technique, catheter is inserted into any large peripheral artery or vein with the help of fluoroscopy by catheter whole procedure.

Interventional cardiology provides controlled bleeding and fast recovery within a short period of time and reduce the complications for patients. The most commonly used interventional cardiology devices include balloon-inflation devices, coronary stents, and cutting balloon catheters among others. Increase in the incidence rate of various cardiovascular diseases, a rise in preference for minimally invasive procedures, growing clinical trials for the novel interventional cardiology devices, and technological advancements of devices are anticipated to fuel the interventional cardiology market over the forecast period. Moreover, favourable reimbursement policies for the devices, lifestyle changes, and rise in product launchings might bolster the market. However, stringent regulatory policies, product recall, high cost for the manufacturing of interventional cardiology devices & treatments, and lack of skilled professionals are expected to dampen the market over the forecast period.

Furthermore, the increasing incidence of cardiovascular disease along with the growing healthcare expenditure in medical devices is expected to push the market growth in the forecasted years. In addition, the rise in tobacco consumption and the growing incidence of obesity is also expected to fuel the growth. Several government and non-government organizations including educational institutes and key market payers, have conducted public awareness campaigns to raise awareness regarding cardiac disease and its treatments. The advancement of technology and procedures in healthcare facilities like innovative cardiovascular devices and regulatory approvals are expected to fuel the growth of the market in the forecasted years. However, the huge cost of interventional cardiac devices and the availability of alternative cardiac disease treatments are expected to hinder the growth of the market in the forecasted years. 

Key Developments

  • In July 2021, Abbott launched its product XIENCE family of stents, which got USFDA’s approval for one month DAPT labeling for patients with high bleeding risk in US.

Interventional Cardiology Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Interventional Cardiology Devices Market Dynamics

Interventional cardiology devices market is growing at a significant CAGR owing to rise in demand for minimally invasive procedures and increase in the prevalence of various cardiac diseases around the globe. According to World Health Organization, approximately 17.3 Mn people died from CVDs in 2008 which is anticipated to reach 23.6 Mn by 2030. Most of the international players are focusing on innovation of novel products with minimally invasive procedures which are expected to upsurge the revenue of the market.

Moreover, acquisitions & mergers, collaborations, product approvals and launching, and patent filings are the strategies followed by the companies for dominating the market. For instance, in February 2017, Merit Medical Systems acquired interventional cardiology devices from the Argon Medical Devices and Catheter Connections, Inc. for strengthening its interventional cardiology devices portfolio. In addition, in January 2016, in Europe, Svelte Medical Systems launched Slender a sirolimus-eluting coronary stent system used as interventional cardiology device.

Interventional Cardiology Devices Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 14.9 billion

Market Size in 2030

US$ 24.6 billion

Market CAGR

8.9%

By Product Type

  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
  • Stents
  • Catheters
  • Inferior Vena Cava (IVC) Filters
  • Intravascular Ultrasound Systems
  • Left Atrial Appendage (LAA) Devices
  • Others

By Disease Type

  • Congestive Heart Disease
  • Percutaneous Valve Replacement
  • Percutaneous Valve Repair
  • Coronary Thrombectomy
  • Others

By End User

  • Hospitals
  • Clinics
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Features of the Report

  • The interventional cardiology devices market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The global interventional cardiology devices market size was valued at US$ 14.9 billion in 2023 and is projected to grow at a CAGR of 8.9% from 2024-2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The interventional cardiology devices market ABIOMED Inc, ACIST Medical Systems, B. Braun Melsungen AG, Biotronik SE & Co., Boston Scientific Corporation, Cardinal Health

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Interventional Cardiology Devices Market Introduction 
2.1.Global Interventional Cardiology Devices Market  - Taxonomy
2.2.Global Interventional Cardiology Devices Market  - Definitions
2.2.1.Product Type 
2.2.2.Disease Type
2.2.3.End User
2.2.4.Region
3.Global Interventional Cardiology Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Interventional Cardiology Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Interventional Cardiology Devices Market  By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Stents
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Catheters
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Inferior Vena Cava (IVC) Filters
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Intravascular Ultrasound Systems
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Left Atrial Appendage (LAA) Devices
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Others
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
6.Global Interventional Cardiology Devices Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Congestive Heart Disease
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Percutaneous Valve Replacement
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Percutaneous Valve Repair
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Coronary Thrombectomy
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Interventional Cardiology Devices Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Cardiac Catheterization Labs
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Ambulatory Surgical Centres
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Interventional Cardiology Devices Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
9.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
9.1.3.Stents
9.1.4.Catheters
9.1.5.Inferior Vena Cava (IVC) Filters
9.1.6.Intravascular Ultrasound Systems
9.1.7.Left Atrial Appendage (LAA) Devices
9.1.8.Others
9.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Congestive Heart Disease
9.2.2.Percutaneous Valve Replacement
9.2.3.Percutaneous Valve Repair
9.2.4.Coronary Thrombectomy
9.2.5.Others
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Cardiac Catheterization Labs
9.3.4.Ambulatory Surgical Centres
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
10.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
10.1.3.Stents
10.1.4.Catheters
10.1.5.Inferior Vena Cava (IVC) Filters
10.1.6.Intravascular Ultrasound Systems
10.1.7.Left Atrial Appendage (LAA) Devices
10.1.8.Others
10.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Congestive Heart Disease
10.2.2.Percutaneous Valve Replacement
10.2.3.Percutaneous Valve Repair
10.2.4.Coronary Thrombectomy
10.2.5.Others
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Cardiac Catheterization Labs
10.3.4.Ambulatory Surgical Centres
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
11.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
11.1.3.Stents
11.1.4.Catheters
11.1.5.Inferior Vena Cava (IVC) Filters
11.1.6.Intravascular Ultrasound Systems
11.1.7.Left Atrial Appendage (LAA) Devices
11.1.8.Others
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Congestive Heart Disease
11.2.2.Percutaneous Valve Replacement
11.2.3.Percutaneous Valve Repair
11.2.4.Coronary Thrombectomy
11.2.5.Others
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Cardiac Catheterization Labs
11.3.4.Ambulatory Surgical Centres
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
12.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
12.1.3.Stents
12.1.4.Catheters
12.1.5.Inferior Vena Cava (IVC) Filters
12.1.6.Intravascular Ultrasound Systems
12.1.7.Left Atrial Appendage (LAA) Devices
12.1.8.Others
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Congestive Heart Disease
12.2.2.Percutaneous Valve Replacement
12.2.3.Percutaneous Valve Repair
12.2.4.Coronary Thrombectomy
12.2.5.Others
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Cardiac Catheterization Labs
12.3.4.Ambulatory Surgical Centres
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
13.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
13.1.3.Stents
13.1.4.Catheters
13.1.5.Inferior Vena Cava (IVC) Filters
13.1.6.Intravascular Ultrasound Systems
13.1.7.Left Atrial Appendage (LAA) Devices
13.1.8.Others
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Congestive Heart Disease
13.2.2.Percutaneous Valve Replacement
13.2.3.Percutaneous Valve Repair
13.2.4.Coronary Thrombectomy
13.2.5.Others
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Cardiac Catheterization Labs
13.3.4.Ambulatory Surgical Centres
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.ABIOMED Inc.
14.2.2.ACIST Medical Systems
14.2.3.B. Braun Melsungen AG
14.2.4.Biotronik SE & Co.
14.2.5.Boston Scientific Corporation
14.2.6.Cardinal Health
14.2.7.Edwards Lifesciences Corporation
14.2.8.Johnson & Johnson Services Inc.
14.2.9.Medtronic
14.2.10.Merit Medical Systems
14.2.11.Koninklijke Philips N.V.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • ABIOMED Inc.
  • ACIST Medical Systems
  • B. Braun Melsungen AG
  • Biotronik SE & Co.
  • Boston Scientific Corporation
  • Cardinal Health
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services Inc.
  • Medtronic
  • Merit Medical Systems
  • Koninklijke Philips N.V.
  • Abbott
  • Terumo Corporation
  • Rontis Corporation Inc.
  • Biosensors International Group Ltd.

Related Industry Reports